WO170
WO170 is a KCNT1 inhibitor that can be used in studies related to diseases associated with KCNT1 dysfunction, such as epilepsy.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 3109711-34-1
- Formule: C25H21N5O
- Masse moléculaire:407.47
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
WO170 (I‑1a) is a KCNT1 channel inhibitor, with an IC50 ≤ 250 nM in the FLIPR thallium flux functional inhibition assay performed on HEK293 cells stably expressing human KCNT1[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 3109711-34-1
-
Masse moléculaire 407.47
-
Formule C25H21N5O
-
SMILES
N#CC1=CC2=C(N[C@H]3CCCC4=C3N=C(O4)C5=CC(C6CC6)=NC=C5)N=CC=C2C=C1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
WO170 Related Classifications
HY-187836 Related Classifications
Powered by Bioz
- WO170
- 3109711-34-1
- WO 170
- WO-170
- Drug Derivative
- refractory epilepsy
- post-traumatic epilepsy
- focal epilepsy
- infantile epilepsy with migrating focal seizures
- KCNT1
- generalized epilepsy
- sleep-related hypermotor epilepsy
- autosomal dominant nocturnal frontal lobe epilepsy
- epilepsy
- epileptic encephalopathy
- Inhibitor
- inhibitor
- inhibit